Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Frontiers in Pharmacology|May 16, 2012
mGlu5 Receptor Functional Interactions and AddictionRobyn M Brown, Sanam Mustafa, Mohammed Akli Ayoub, et al.
Cellular Signalling|February 24, 2006
Extended bioluminescence resonance energy transfer (eBRET) for monitoring prolonged protein-protein interactions in live cellsKevin D G Pfleger, Jasmin R Dromey, Matthew B Dalrymple, et al.
Scientific Reports|December 19, 2019
I8-arachnotocin-an arthropod-derived G protein-biased ligand of the human vasopressin V2 receptorLeopold Duerrauer, Edin Muratspahić, Jasmin Gattringer, et al.
International Journal of Molecular Sciences|January 27, 2021
Investigation of Receptor Heteromers Using NanoBRET Ligand BindingElizabeth K M Johnstone, Heng B See, Rekhati S Abhayawardana, et al.
Cellular Signalling|July 12, 2011
Heteromerization of angiotensin receptors changes trafficking and arrestin recruitment profilesEnzo R Porrello, Kevin D G Pfleger, Ruth M Seeber, et al.
Biochemical Pharmacology|March 20, 2021
Complex interactions between the angiotensin II type 1 receptor, the epidermal growth factor receptor and TRIO-dependent signaling partnersElizabeth K M Johnstone, Rekhati S Abhayawardana, Heng B See, et al.
Frontiers in Endocrinology|June 20, 2022
Novel Pharmacology Following Heteromerization of the Angiotensin II Type 2 Receptor and the Bradykinin Type 2 ReceptorElizabeth K M Johnstone, Mohammed Akli Ayoub, Rebecca J Hertzman, et al.
The Journal of Biological Chemistry|February 29, 2012
Identification and profiling of novel α1A-adrenoceptor-CXC chemokine receptor 2 heteromerSanam Mustafa, Heng B See, Ruth M Seeber, et al.
International Journal of Molecular Sciences|December 31, 2020
Insights into the Interaction of LVV-Hemorphin-7 with Angiotensin II Type 1 ReceptorAmanat Ali, Elizabeth K M Johnstone, Bincy Baby, et al.
Plos One|March 27, 2012
Deleterious GRM1 mutations in schizophreniaMohammed Akli Ayoub, Dora Angelicheva, David Vile, et al.
Pageof 7